Sabra (SBRA) Q2 Revenue Jumps 7.4%

Sabra Health Care REIT (SBRA) reported Q2 2025 results that significantly exceeded analyst expectations, with normalized FFO per share of $0.37 against estimates of $0.17, and GAAP revenue of $189.15 million, a 7.4% year-over-year increase. This strong outperformance was primarily driven by the managed senior housing segment, which saw a 17.1% year-over-year increase in same-store Cash NOI, aligning with Sabra's strategic shift towards this area. The company also demonstrated improved financial health by refinancing debt, reducing net debt to adjusted EBITDA to 5.00x, and maintaining substantial liquidity and its quarterly dividend, signaling robust operational execution and prudent financial management.

Analysis

Sabra Health Care REIT (SBRA) delivered a robust Q2 2025 performance, significantly exceeding market expectations and demonstrating strong execution on its strategic initiatives. The company reported a normalized FFO per share of $0.37, more than double the analyst consensus of $0.17, alongside a 7.4% year-over-year revenue increase to $189.15 million. This outperformance was primarily fueled by the managed senior housing segment, which posted a notable 17.1% year-over-year increase in same-store cash NOI, validating the company's strategic shift to expand this segment's portfolio share to 30%. Financial health has visibly improved, evidenced by a reduction in net debt to adjusted EBITDA to 5.00x from 5.19x in the prior quarter and a proactive refinancing of $500 million in debt that will lower future interest expenses. The stability in the triple-net portfolio, coupled with improving tenant health in skilled nursing facilities where EBITDARM coverage rose to 2.27x, provides a solid operational foundation. Furthermore, the updated FY2025 guidance, which projects low- to mid-teens growth in managed senior housing cash NOI, does not yet incorporate a $220 million pipeline of awarded deals, suggesting potential for further upside to earnings upon closing.

Key Decisions for Investors

• Given the significant earnings outperformance and strong operational momentum in the high-growth managed senior housing segment, investors could interpret these results as a strong validation of the company's strategic pivot.
• It is crucial to monitor the execution of the $220 million investment pipeline, as successful integration at the projected high-7% yields could serve as a material upside catalyst to earnings not currently reflected in full-year guidance.
• The improved leverage profile to 5.00x and strong liquidity of $1.2 billion enhance the safety of the maintained $0.30 quarterly dividend, but investors should remain watchful of potential equity dilution from future issuances used to fund growth.
• While the improving EBITDARM coverage in the skilled nursing portfolio is a positive de-risking signal, this metric warrants continued observation as new Medicare and Medicaid reimbursement rates are implemented through 2025.